• 0 Comments 0 Shares 12 Views 0 Reviews
  • SPORTS.YAHOO.COM
    BenitoVillamarnStadium enters first phase of major renovation
    Acciona and Real BetisBalompihave begun renovations at Sevilles BenitoVillamarnStadium, launching the first phase of a multi-stage redevelopment project.Theprojectaims to increase the venues capacity and update the facility,Accionasaid.The current phase involves excavation and installation of diaphragm retaining walls in preparation for new below-ground levels.In the coming months, bothparties,operatingunder a joint delivery model, will continue to refine technical aspects of the project and optimise the final design.The collaborative approach aims to integrate solutions developed by bothAccionaand Real BetisBalompi.Subsequentphases will see the construction of a new stand, refurbishment of existing seating areas,including Gol Norte, Fondo and Gol Sur, and the building of an adjacent mixed-use structure.Plans also cover the addition of several underground parking floors, a new roof and a facade for the entire stadium.Construction activity will be organised tomaintainurban mobility and manage noise to reduce disruption to theHelipolisneighbourhood surrounding the stadium.The redevelopment aims toestablishBenitoVillamarnStadium as aleading urban and sports landmarkin Seville, with plans to introduce new architectural designs, improved functionality, advanced technology and notable upgrades for supporters.Previously,Accionadelivered the Rafael Gordillo Training Complex in Dos Hermanas, which features football pitches, shared dressing rooms, office space, a gymnasium, medical facilities and meeting rooms.The development also included supporting buildings for maintenance and control, connected road infrastructure and urbanisation of the area.This training facility was designed with an emphasis on sustainability measures,including bioclimatic features, natural ventilation, energy efficiency, water reuse systems and integration of renewable energy, aligning with Real Betiss Forever Green environmental programme.Accionahas alsobeen responsible forconstructing large-scale sports infrastructure elsewhere in Spain, such as Bilbao's SanMamsStadium and the training complex for Club Deportivo Tenerife. "BenitoVillamarnStadium enters first phase of major renovation" was originally created and published by World Construction Network, a GlobalData owned brand.The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
    0 Comments 0 Shares 14 Views 0 Reviews
  • 0 Comments 0 Shares 14 Views 0 Reviews
  • WWW.ESPN.COM
    Despite Bara's strong effort, Atlti end their Champions League hopes
    Barcelona looked to stage a comeback, but Atltico Madrid did enough to prevent the Blaugrana from advancing.
    0 Comments 0 Shares 15 Views 0 Reviews
  • Inflammatory Bowel Disease Therapeutics Market
    Market Insights
    The Inflammatory Bowel Disease Therapeutics Market is experiencing steady expansion as the global prevalence of chronic gastrointestinal disorders continues to rise. Inflammatory Bowel Disease (IBD), including Crohn’s disease and ulcerative colitis, requires long-term management through advanced therapeutic solutions such as biologics, small molecules, corticosteroids, and immunomodulators. Increasing awareness, improved diagnosis rates, and continuous drug innovation are significantly driving market growth.
    Get more info: https://www.trendvaultresearch.com/report/inflammatory-bowel-disease-therapeutics-1010
    One of the key drivers of the market is the rising incidence of IBD worldwide, particularly in urban populations where lifestyle changes, diet patterns, and environmental factors contribute to disease development. As patient numbers increase, healthcare systems are focusing more on long-term treatment strategies and targeted therapies to improve quality of life and reduce complications.
    Another major growth factor is the rapid advancement in biologic therapies and precision medicine. Modern treatments such as TNF inhibitors, IL inhibitors, and JAK inhibitors are transforming disease management by directly targeting inflammatory pathways. These therapies offer improved efficacy compared to traditional approaches, especially for patients with moderate to severe conditions.
    The market is also benefiting from strong pharmaceutical research pipelines and regulatory support for novel drug approvals. Increasing investments in clinical trials and biotechnology innovation are accelerating the introduction of next-generation therapies. Recent developments in oral small molecules are also improving patient convenience and treatment adherence.
    However, challenges such as high treatment costs, long-term safety concerns, and biosimilar competition continue to impact market dynamics. Despite these limitations, growing healthcare expenditure and expanding access to advanced therapies in emerging economies are expected to support sustained growth.
    Looking ahead, the Inflammatory Bowel Disease Therapeutics Market is projected to expand steadily as innovation in biologics, personalized medicine, and digital healthcare solutions continues to evolve. The shift toward targeted and patient-centric treatment approaches will play a crucial role in shaping the future of IBD management.

    Contact Information
    TrendVault Research
    Email: sales@trendvaultresearch.com
    Website: www.trendvaultresearch.com

    #IBDMarket #InflammatoryBowelDisease #TherapeuticsMarket #Biologics #HealthcareInnovation #CrohnsDisease #UlcerativeColitis #PharmaceuticalIndustry #PrecisionMedicine #FutureOfHealthcare
    Inflammatory Bowel Disease Therapeutics Market Market Insights The Inflammatory Bowel Disease Therapeutics Market is experiencing steady expansion as the global prevalence of chronic gastrointestinal disorders continues to rise. Inflammatory Bowel Disease (IBD), including Crohn’s disease and ulcerative colitis, requires long-term management through advanced therapeutic solutions such as biologics, small molecules, corticosteroids, and immunomodulators. Increasing awareness, improved diagnosis rates, and continuous drug innovation are significantly driving market growth. Get more info: https://www.trendvaultresearch.com/report/inflammatory-bowel-disease-therapeutics-1010 One of the key drivers of the market is the rising incidence of IBD worldwide, particularly in urban populations where lifestyle changes, diet patterns, and environmental factors contribute to disease development. As patient numbers increase, healthcare systems are focusing more on long-term treatment strategies and targeted therapies to improve quality of life and reduce complications. Another major growth factor is the rapid advancement in biologic therapies and precision medicine. Modern treatments such as TNF inhibitors, IL inhibitors, and JAK inhibitors are transforming disease management by directly targeting inflammatory pathways. These therapies offer improved efficacy compared to traditional approaches, especially for patients with moderate to severe conditions. The market is also benefiting from strong pharmaceutical research pipelines and regulatory support for novel drug approvals. Increasing investments in clinical trials and biotechnology innovation are accelerating the introduction of next-generation therapies. Recent developments in oral small molecules are also improving patient convenience and treatment adherence. However, challenges such as high treatment costs, long-term safety concerns, and biosimilar competition continue to impact market dynamics. Despite these limitations, growing healthcare expenditure and expanding access to advanced therapies in emerging economies are expected to support sustained growth. Looking ahead, the Inflammatory Bowel Disease Therapeutics Market is projected to expand steadily as innovation in biologics, personalized medicine, and digital healthcare solutions continues to evolve. The shift toward targeted and patient-centric treatment approaches will play a crucial role in shaping the future of IBD management. Contact Information TrendVault Research Email: sales@trendvaultresearch.com Website: www.trendvaultresearch.com #IBDMarket #InflammatoryBowelDisease #TherapeuticsMarket #Biologics #HealthcareInnovation #CrohnsDisease #UlcerativeColitis #PharmaceuticalIndustry #PrecisionMedicine #FutureOfHealthcare
    WWW.TRENDVAULTRESEARCH.COM
    Inflammatory Bowel Disease Therapeutics Expansion Opportunities & Forecast Analysis 2033 | Market Research Report
    The Inflammatory Bowel Disease (IBD) therapeutics market is booming, projected to reach \$23.1 billion by 2033, driven by rising prevalence and innovative treatments. This in-depth analysis explores market size, growth, key players (AbbVie, J&J, GSK, Merck, Novartis), and future trends in IBD drugs. Learn more!
    0 Comments 0 Shares 848 Views 0 Reviews
  • レコメンデーションエンジン市場規模、シェア、成長動向分析、予測(2024年~2033年)
    概要 世界のレコメンデーションエンジン市場は、業界全体でパーソナライズされたデジタル体験への需要の高まりを背景に、急速な成長を遂げています。レコメンデーションエンジンは、高度なアルゴリズムとデータ分析を活用し、個々の好みや行動に基づいて、カスタマイズされたコンテンツ、製品提案、ユーザー体験を提供します。これらのシステムは、顧客エンゲージメントの向上、コンバージョン率の改善、収益成長の促進を目的として、企業に広く採用されています。 包括的な市場インサイトはこちらをご覧ください:https://straitsresearch.com/jp/report/recommendation-engines-market eコマース、ストリーミングサービス、ソーシャルメディアなどのデジタルプラットフォームの普及は、レコメンデーションエンジンの導入を大きく後押ししています。...
    0 Comments 0 Shares 109 Views 0 Reviews
  • WWW.DAILYMAIL.CO.UK
    Hugo Ekitike 'out of the World Cup and rest of Liverpool's season': Worrying reports emerge from France on 79m striker's injury
    Hugo Ekitike has been ruled out of this summer's World Cup after pulling up with an injury on Tuesday night, according to reports in France.
    0 Comments 0 Shares 14 Views 0 Reviews
  • Sportivo Network is happy to welcome new sports influencers
    0 Comments 0 Shares 25 Views 0 Reviews
  • WWW.GBNEWS.COM
    David Wilkie's son quits job to attempt to match Olympic legend's swimming record for charity
    Adam Wilkie has handed in his notice and embarked on what he calls a "Hail Mary" mission spending an entire year training to match the swimming time his late father set half a century ago.The 33-year-old marketing manager, whose closest brush with sport at work was a standing desk, is attempting to swim 200 metres breaststroke in 2 minutes 15.11 seconds.That's the world record his dad David Wilkie set when he stormed to Olympic gold in Montreal back in 1976."He would think I am mad because he knows how hard it was," Adam says. "He knows how hard swimming is and how much work he put in to get to that time."David, one of Britain's most celebrated Olympians, passed away from cancer in 2024 at the age of 70.His son hopes the challenge will raise 215,000 for SportsAid while honouring the man he lost far too soon.David Wilkie was just 22 when he touched the wall in Montreal, smashing the previous world record by more than three seconds.It was a moment that ended 68 years of waiting for a British men's swimming gold medal.Born in Sri Lanka to Scottish parents, he moved to Edinburgh and joined Warrender Baths at 11 under coach Frank Thomas.By the time he hung up his goggles, he held British, European, Commonwealth, American NCAA and Olympic titles simultaneously something nobody has managed before or since.He was a true pioneer too, becoming the first swimmer to wear both a cap and goggles in competition.With his flowing locks tucked away and that famous bushy moustache, he cut quite the figure.Duncan Goodhew, who won Olympic gold in Moscow in 1980, called him "a swimming god" upon his death.For Adam, this challenge runs far deeper than chasing a time on a clock.He never saw his father compete professionally he wasn't born until 1993, 17 years after David retired.Swimming always felt like his dad's story, separate from their family life together.But after David died, something shifted."When he died, it felt like a natural way to feel close to him," Adam explains. "While you swim, you're staring at a line so you've got a lot of time to think."He found himself having conversations with his father in the water, even though David was no longer there."This is my way of processing the grief of losing him and making sense of what he left behind," he says. "It's my way of having one last conversation with him."There's a touching irony too Adam was actually scared of deep water as a child and still doesn't love the deep end.Adam has quit his London job as a senior global brand manager at Bulldog Skincare to throw himself into training full-time.He's been saving up to make it happen, and the support behind him is impressive.Aquatics GB will provide access to world-class coaching, cutting-edge sports science and elite training facilities.Duncan Goodhew is backing the challenge too, saying: "Adam isn't just chasing a record. He's trying to understand his father, his mindset, and his journey."The 215,000 fundraising target for SportsAid is no random figure it mirrors that iconic 2:15.11 time.The charity gave David its very first recognition award back in 1976, making the connection even more meaningful.Adam's journey will take him through his father's life, from the Scottish pools where it all began to Miami, where David became a three-time NCAA champion, and finally to Montreal itself.Yet for all his Olympic glory, David was simply "dad" to Adam and his sister Natasha."I remember watching him swimming and it was like he manipulated the water," Adam recalls. "He'd dive into the ocean and disappear under the surface and come up 50 metres away he was like a fish."Family holidays meant splashing about together in Loch Morlich near Aviemore, not training sessions.David was famously humble about his achievements, never boastful, always at ease with himself.Adam hopes this challenge will demonstrate just how extraordinary elite swimmers truly are while bringing his father's legacy to a new generation."I think he would be proud that his son is trying to do something to remember him," Adam says.Drew Barrand, Aquatics GB Chief Executive, puts it beautifully: "By chasing his father's 2:15.11 record, he's not just honouring history he's shining a light on the next generation of swimmers."Our Standards: The GB News Editorial Charter
    0 Comments 0 Shares 15 Views 0 Reviews
  • WWW.BBC.COM
    Watch: Moment gunman tackled by school principal in Oklahoma
    CCTV footage shows a high school principal charging towards a former student who was armed in Oklahoma.
    0 Comments 0 Shares 15 Views 0 Reviews